Wolverine Trading’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-897
| Closed | -$26.9K | – | 1253 |
|
|
2023
Q2 | $26.9K | Sell |
897
-902
| -50% | -$27.1K | ﹤0.01% | 1029 |
|
|
2023
Q1 | $67K | Buy |
+1,799
| New | +$67K | ﹤0.01% | 910 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1096 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 1297 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1270 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1595 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1880 |
|
|
2021
Q1 | – | Sell |
-1,664
| Closed | -$116K | – | 1835 |
|
|
2020
Q4 | $116K | Buy |
+1,664
| New | +$116K | ﹤0.01% | 1324 |
|
|
2020
Q1 | – | Sell |
-1,370
| Closed | -$88K | – | 1347 |
|
|
2019
Q4 | $88K | Sell |
1,370
-713
| -34% | -$45.8K | ﹤0.01% | 1321 |
|
|
2019
Q3 | $121K | Sell |
2,083
-1,116
| -35% | -$64.8K | ﹤0.01% | 1110 |
|
|
2019
Q2 | $190K | Buy |
3,199
+2,161
| +208% | +$128K | ﹤0.01% | 980 |
|
|
2019
Q1 | $68K | Buy |
+1,038
| New | +$68K | ﹤0.01% | 1113 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1593 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1314 |
|